Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from NYSE

Eli Lilly Plans To Invest €400M In Manufacturing Facility In Ireland: Report

Eli Lilly And Co (NYSE: LLY) plans to invest more than €400 million into a new manufacturing facility in Limerick, Ireland, according to a

Benzinga

Apple CEO Tim Cook Said: Apple Company Sees A Lot Of Potential In The Metaverse

Apple (NASDAQ: AAPL) CEO Tim Cook addressed the idea of the “metaverse.” In response to a question from Morgan Stanley (NYSE: MS) analyst Katy Huberty, Cook explained that

Benzinga

Disney Inks Streaming Deal With WWE For Indonesia Market: Will More Markets Follow?

Walt Disney Co (NYSE: DIS) has signed a deal with World Wrestling Entertainment, Inc. (NYSE: WWE) to exclusively stream WWE Network programming in Indonesia on the Disney+ Hotstar service.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

33 Stocks Moving In Friday's Mid-Day Session

Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 126% to $2.6219. Imperial Petroleum, last month, posted Q3 revenue of $4.1 million.

Benzinga

Pfizer Whale Trades For January 28

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 16 strange trades.

Benzinga

Check Out What Whales Are Doing With Home Depot

A whale with a lot of money to spend has taken a noticeably bearish stance on Home Depot. Looking at options history for Home Depot (NYSE:HD) we detected 20 strange trades.

Benzinga

Expert Ratings For Raymond James Financial

Raymond James Financial (NYSE:RJF) has observed the following analyst ratings within the last quarter:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Carnival Whale Trades For January 28

Someone with a lot of money to spend has taken a bullish stance on Carnival (NYSE:CCL). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Where Chewy Stands With Analysts

Within the last quarter, Chewy (NYSE:CHWY) has observed the following analyst ratings:

Benzinga

What 5 Analyst Ratings Have To Say About Laboratory Corp

Analysts have provided the following ratings for Laboratory Corp (NYSE:LH) within the last quarter:

Benzinga

Analyst Ratings For Dover

Within the last quarter, Dover (NYSE:DOV) has observed the following analyst ratings:

Benzinga

Ford Stock Holds Above This Key Level: What To Watch As Earnings Approach

Ford Motor, Inc (NYSE: F) gapped down slightly lower on Friday in sympathy with the SPDR S&P 500 (NYSE: SPY), which was trading down about 0.55%.

Benzinga

Check Out What Whales Are Doing With RBLX

A whale with a lot of money to spend has taken a noticeably bullish stance on Roblox. Looking at options history for Roblox (NYSE:RBLX) we detected 11 strange trades.

Benzinga

If You Invested $1,000 In Tesla Stock One Year Ago, Here's How Much You'd Have Now

Investors who have owned stocks in the last year have generally experienced some decent gains. In fact, the SPDR S&P 500 ETF Trust (NYSE: SPY) total return over the past 12 months is 16.7%. But there is no question some big-name stocks performed better than others along the way.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

FuboTV Shares Gain On Analyst Upgrade

LightShed Partners analyst Richard Greenfield upgraded FuboTV Inc (NYSE:FUBO) to Neutral from Sell and removed his $6.50 price target. The re-rating follows the stock's selloff. Fubo shares are down nearly 85% in 13 months while the company is sitting on $375 million of cash, Greenfield notes. The analyst is taking a wait-and-see approach on whether…

Benzinga

Why BofA Sees 'Better Entry Point' In Ginkgo Bioworks Stock

Ginkgo Bioworks Holdings Inc (NYSE: DNA) is “at the forefront of the rising SynBio wave, a market we think holds much long-term promise,” according to BofA Securities.

Benzinga

Why Are Williams Industrial Services Shares Trading Lower Today?

Williams Industrial Services Group Inc (NYSE:WLMS) plunges after providing FY22 financial guidance. The company expects revenue of $305 million - $325 million (consensus $325.04 million), with the first quarter being the lowest sales period. The company expects gross margin to be 10.5% - 11.0%, and EBITDA of $10 million - $12.5 million.…

Benzinga

Citigroup Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bullish stance on Citigroup. Looking at options history for Citigroup (NYSE:C) we detected 17 strange trades.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Expert Ratings For Target

Analysts have provided the following ratings for Target (NYSE:TGT) within the last quarter:

Benzinga

Analyst Ratings For Juniper Networks

Over the past 3 months, 7 analysts have published their opinion on Juniper Networks (NYSE:JNPR) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

What 11 Analyst Ratings Have To Say About Rockwell Automation

Over the past 3 months, 11 analysts have published their opinion on Rockwell Automation (NYSE:ROK) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Stocks That Hit 52-Week Highs On Friday

Friday's session saw 10 companies set new 52-week highs.

Benzinga

Where Veeva Systems Stands With Analysts

Analysts have provided the following ratings for Veeva Systems (NYSE:VEEV) within the last quarter:

Benzinga

Where Northrop Grumman Stands With Analysts

Over the past 3 months, 4 analysts have published their opinion on Northrop Grumman (NYSE:NOC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Eli Lilly Expects FDA Rejection For Expanded Use Baricitinib For Eczema

Based on top-line efficacy results from two pivotal Phase 3 trials Eli Lilly And Co (NYSE: LLY) has decided to

1 … 705 706 707 708

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.